Azitra (AZTR) Cash & Equivalents (2022 - 2026)
Azitra (AZTR) recorded Cash & Equivalents of $6.73 million in Q2 2026, up 543.4% from $1.05 million a year earlier but down 33.1% from the prior quarter.
Powered by 
Analysis
Azitra (AZTR) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Azitra reported Cash & Equivalents of $2.07 million, down 54.6% from FY2024.
- Annual Cash & Equivalents has a three-year compound annual growth rate of -16.0% (FY2022 to FY2025).
- Across earlier years, Cash & Equivalents came in at $4.55 million in FY2024 (+153.6%), $1.8 million in FY2023 (-48.6%) and $3.49 million in FY2022.
- Quarterly Cash & Equivalents has ranged from $803,082 in Q2 2024 to $10.05 million in Q1 2026 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in six of the last eight quarters, with growth averaging 109.6%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 543.4% in Q2 2026, against a decline of 87.2% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.05 million (Q1 2026), $2.07 million (Q4 2025) and $1.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Azitra | 1.35 Mn | -18.90 Mn | - | 6.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.73 Mn |
| Mar 31, 2026 | 10.05 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 3.21 Mn |
| Dec 31, 2024 | 4.55 Mn |
| Sep 30, 2024 | 7.26 Mn |
| Jun 30, 2024 | 803,082.00 |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Dec 31, 2022 | 3.49 Mn |
API Access
Azitra Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AZTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AZTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AZTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();